Selected article for: "clinical efficacy and mRNA vaccine"

Author: Abu Jabal, Kamal; Ben-Amram, Hila; Beiruti, Karine; Batheesh, Yunis; Sussan, Christian; Zarka, Salman; Edelstein, Michael
Title: Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021
  • Cord-id: a1rnfvic
  • Document date: 2021_2_11
  • ID: a1rnfvic
    Snippet: The BNT162b2 mRNA COVID-19 vaccine showed high efficacy in clinical trials but observational data from populations not included in trials are needed. We describe immunogenicity 21 days post-dose 1 among 514 Israeli healthcare workers by age, ethnicity, sex and prior COVID-19 infection. Immunogenicity was similar by ethnicity and sex but decreased with age. Those with prior infection had antibody titres one magnitude order higher than naïve individuals regardless of the presence of detectable Ig
    Document: The BNT162b2 mRNA COVID-19 vaccine showed high efficacy in clinical trials but observational data from populations not included in trials are needed. We describe immunogenicity 21 days post-dose 1 among 514 Israeli healthcare workers by age, ethnicity, sex and prior COVID-19 infection. Immunogenicity was similar by ethnicity and sex but decreased with age. Those with prior infection had antibody titres one magnitude order higher than naïve individuals regardless of the presence of detectable IgG antibodies pre-vaccination.

    Search related documents:
    Co phrase search for related documents
    • acute infection and additional protection: 1, 2, 3
    • acute infection and adjusted analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and long suggest: 1, 2, 3, 4, 5, 6, 7
    • adjusted analysis and long suggest: 1